February 9, 2026 · Form 4 insider transaction
Hunt Hazel sold 77,968 shares of Corcept Therapeutics Incorporated at $41.31 per share, a transaction worth $3.22M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 26, 2026.